日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial

纳武利尤单抗联合伊匹木单抗治疗晚期卵巢癌和子宫内膜透明细胞癌:一项非随机临床试验

Gao, Bo; Carlino, Matteo S; Michael, Michael; Underhill, Craig; Marshall, Henry; Gunjur, Ashray; So, Jane; Kee, Damien; Antill, Yoland; Lam, Wei-Sen; Chan, Howard; Harrup, Rosemary; Hamilton, Anne; Grady, John; Ballinger, Mandy; Tavancheh, Elnaz; Yoon, Won-Hee; Palmer, Jodie; Thomas, David; Wilkie, Kylie; Cebon, Jonathan; Klein, Oliver

Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.

先天性传感器 NOD2 中常见的遗传性功能丧失突变会导致对癌症免疫疗法产生异常的免疫反应

Barnet Megan B, Jackson Katherine J L, Masle-Farquhar Etienne, Russell Amanda, Burnett Deborah L, Chye Adrian, Jara Chris J, Faulks Megan, Mawson Amanda, Peters Timothy J, Brink Robert, Wright Katherine, Allen India, Junankar Simon, Davis Ian D, Heller Gillian, Khan Zia, Bruce Jeffrey, Yang Cindy, Prokopec Stephenie, Pugh Trevor, Behren Andreas, Hold Georgina L, Zhang Fan, Cooper Wendy A, Gao Bo, Nagrial Adnan, Joshua Anthony M, John Thomas, Peters Geoffrey, Hui Rina, Boyer Michael, Blinman Prunella L, Kao Steven C, Cebon Jonathan, Goodnow Christopher C

A gut microbial signature for combination immune checkpoint blockade across cancer types

针对不同癌症类型联合免疫检查点阻断的肠道微生物特征

Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Ben Markman, Damien Kee, Matteo S Carlino, Craig Underhill, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley0

A dataset of logistics sites in England and Wales: Location, size, type and loading bays

英格兰和威尔士物流站点的数据集:位置、规模、类型和装卸货区

de Saxe, Christopher; Ainalis, Daniel; Cebon, David

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

阻断共抑制分子PD-1可激活黑色素瘤中ILC2依赖的抗肿瘤免疫

Jacquelot, Nicolas; Seillet, Cyril; Wang, Minyu; Pizzolla, Angela; Liao, Yang; Hediyeh-Zadeh, Soroor; Grisaru-Tal, Sharon; Louis, Cynthia; Huang, Qiutong; Schreuder, Jaring; Souza-Fonseca-Guimaraes, Fernando; de Graaf, Carolyn A; Thia, Kevin; Macdonald, Sean; Camilleri, Mary; Luong, Kylie; Zhang, Shengbo; Chopin, Michael; Molden-Hauer, Tristan; Nutt, Stephen L; Umansky, Viktor; Ciric, Bogoljub; Groom, Joanna R; Foster, Paul S; Hansbro, Philip M; McKenzie, Andrew N J; Gray, Daniel H D; Behren, Andreas; Cebon, Jonathan; Vivier, Eric; Wicks, Ian P; Trapani, Joseph A; Munitz, Ariel; Davis, Melissa J; Shi, Wei; Neeson, Paul J; Belz, Gabrielle T

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

罕见妇科恶性肿瘤患者使用纳武单抗和伊匹单抗进行联合免疫治疗:CA209-538 临床试验结果

Oliver Klein, Damien Kee, Bo Gao, Ben Markman, Jessica da Gama Duarte, Luke Quigley, Louise Jackett, Richelle Linklater, Andrew Strickland, Clare Scott, Linda Mileshkin, Jodie Palmer, Matteo Carlino, Andreas Behren, Jonathan Cebon

Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules

标准剂量帕博利珠单抗联合替代剂量伊匹木单抗治疗晚期黑色素瘤:KEYNOTE-029 队列 1C,一项比较两种给药方案的 2 期随机研究

Georgina V Long,Caroline Robert,Marcus O Butler,Felix Couture,Matteo S Carlino,Steven O'Day,Victoria Atkinson,Jonathan S Cebon,Michael P Brown,Stéphane Dalle,Andrew G Hill,Geoffrey T Gibney,Steven McCune,Alexander M Menzies,Cuizhen Niu,Nageatte Ibrahim,Blanca Homet Moreno,Adi Diab

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma

更正:BCL-XL 是治疗恶性胸膜间皮瘤的一个可靶向靶点。

Arulananda, Surein; O'Brien, Megan; Evangelista, Marco; Harris, Tiffany J; Steinohrt, Nikita S; Jenkins, Laura J; Walkiewicz, Marzena; O'Donoghue, Robert J J; Poh, Ashleigh R; Thapa, Bibhusal; Williams, David S; Leong, Trishe; Mariadason, John M; Li, Xia; Cebon, Jonathan; Lee, Erinna F; John, Thomas; Fairlie, W Douglas

Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538

伊匹木单抗和纳武利尤单抗联合免疫疗法治疗晚期肾上腺皮质癌患者:CA209-538 亚组分析

Klein, Oliver; Senko, Clare; Carlino, Matteo S; Markman, Ben; Jackett, Louise; Gao, Bo; Lum, Caroline; Kee, Damien; Behren, Andreas; Palmer, Jodie; Cebon, Jonathan

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma

一种针对 BCL-XL 和 BCL-2 的新型 BH3 类似物 AZD0466 对恶性胸膜间皮瘤的临床前模型有效

Surein Arulananda, Megan O'Brien, Marco Evangelista, Laura J Jenkins, Ashleigh R Poh, Marzena Walkiewicz, Trishe Leong, John M Mariadason, Jonathan Cebon, Srividya B Balachander, Justin R Cidado, Erinna F Lee #, Thomas John #, Walter D Fairlie #